These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1686184)

  • 1. Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics.
    Kapur S; Ganguli R; Ulrich R; Raghu U
    Schizophr Res; 1991 Dec; 6(1):49-53. PubMed ID: 1686184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
    Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
    J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence studies in schizophrenia.
    Hogarty GE
    Am J Psychiatry; 2004 Mar; 161(3):581-2; author reply 582-3. PubMed ID: 14992994
    [No Abstract]   [Full Text] [Related]  

  • 5. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.
    Garavan J; Browne S; Gervin M; Lane A; Larkin C; O'Callaghan E
    Compr Psychiatry; 1998; 39(4):215-9. PubMed ID: 9675506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining and assessing adherence to oral antipsychotics: a review of the literature.
    Velligan DI; Lam YW; Glahn DC; Barrett JA; Maples NJ; Ereshefsky L; Miller AL
    Schizophr Bull; 2006 Oct; 32(4):724-42. PubMed ID: 16707778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].
    Puschner B; Born A; Giessler A; Helm H; Becker T; Angermeyer MC
    Psychiatr Prax; 2005 Mar; 32(2):62-7. PubMed ID: 15712037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms of schizophrenia and compliance with medication.
    Tattan TM; Creed FH
    Schizophr Bull; 2001; 27(1):149-55. PubMed ID: 11215543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments, and prospects.
    Young JL; Spitz RT; Hillbrand M; Daneri G
    J Am Acad Psychiatry Law; 1999; 27(3):426-44. PubMed ID: 10509942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health beliefs and compliance with antipsychotic medication.
    Budd RJ; Hughes IC; Smith JA
    Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of antipsychotic medication taking in people with schizophrenia.
    McCann TV; Deans C; Clark E; Lu S
    Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
    Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
    Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.